ReviewInternal medicine (Tokyo, Japan)2026
Olanzapine and the Spectrum of Drug-induced Diabetes: Unveiling Dual Risk Factors for Type 2 Diabetes and Acute-onset Ketoacidosis.
Takahiko NagaminePubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.